Blooming Import Inc at 45 Bowne Street, Brooklyn, NY 11231 is recalling Golden Lion Brand Dried Ziziphus Jujuba Mill (Dried Dates) because they contain undeclared sulfites. People who have severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product.
Whole Foods Market Mid-Atlantic Region Recalls Spinach Dip Due to Undeclared Egg
Whole Foods Market Mid-Atlantic Region is recalling an organic creamy spinach dip because it contains eggs, an undeclared allergen.
Read The Complete Story!
Health Matters America Inc. Issues an Allergy Alert on Undeclared Milk in Organic Traditions Brand Dark Chocolate Hazelnuts, Dark Chocolate Hazelnuts with Chili, Dark Chocolate Almonds, and Dark Chocolate Almonds with Chili.
HEALTH MATTERS AMERICA INC. of Cheektowaga, New York is recalling specific lots of ORGANIC TRADITIONS DARK CHOCOLATE HAZELNUTS, ORGANIC TRADITIONS DARK CHOCOLATE HAZELNUTS WITH CHILI, ORGANIC TRADITIONS DARK CHOCOLATE ALMONDS, and ORGANIC TRADITIONS DARK CHOCOLATE ALMONDS WITH CHILI because they were found to contain undeclared milk. People who have an allergy to milk run the risk of serious or life-threatening allergic reaction if they consume these products.
Read The Complete Story!
FDA approves first generic versions of antidepressant drug Cymbalta
The U.S. Food and Drug Administration today approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions.
FDA takes significant steps to address antimicrobial resistance
The U.S. Food and Drug Administration today is implementing a plan to help phase out the use of medically important antimicrobials in food animals for food production purposes, such as to enhance growth or improve feed efficiency. The plan would also phase in veterinary oversight of the remaining appropriate therapeutic uses of such drugs.
FDA approves Sovaldi for chronic hepatitis C
The U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Solvadi is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of interferon.
FDA approves first drug treatment for Peyronie’s disease
The U.S. Food and Drug Administration today approved a new use for Xiaflex (collagenase clostridium histolyticum) as the first FDA-approved medicine to treat men with bothersome curvature of the penis, a condition known as Peyronie’s disease.
FDA reaches $1.25 million settlement with Advanced Sterilization Products and company executives
The U.S. Food and Drug Administration has reached a $1.25 million settlement of a civil money penalty action against Advanced Sterilization Products (ASP), a division of Ethicon Inc., a Johnson & Johnson company, and two of ASP’s executives alleging that ASP manufactured and distributed adulterated and misbranded sterilization monitoring products.
Cargill Conducts Voluntary Recall of Select Nutrena® NatureWise® Meatbird and Chick Starter Feed
Cargill’s animal nutrition business today announced a voluntary recall of two of its Nutrena NatureWise poultry feeds due to incorrect levels of calcium. The affected products were manufactured at Cargill’s facilities in Flora, Ill., Oklahoma City, Okla., Abilene, Texas, and Mineola, Texas, between May 1, 2013 and Nov. 21, 2013.
FDA issues safety communication on HeartStart automated external defibrillators from Philips Healthcare
Certain HeartStart automated external defibrillator (AED) devices made by Philips Medical Systems, a division of Philips Healthcare, may be unable to deliver needed defibrillator shock in a cardiac emergency situation, the U.S. Food and Drug Administration said today in a new safety communication for users of these previously recalled devices.